SIS3 Hydrochloride

SIS3

SIS 3 HCL;SIS-3 HCL;(2E)-1-(6,7-DIMETHOXY-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL)-3-(1-METHYL-2-PHENYL-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)-PROPENONE 盐酸盐;CS-2236;SIS3 盐酸盐

PaMapiMod

PAMAPIMOD

帕吡莫德

ON123300

8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈

CS-2199;ON 123300;ON-123300;ON123300;8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈;ON-​123300;ON 123300;ON-123300

ML234

ML324

CS-2198;ML-324;ML324;ML 324;N-(3-(二甲氨基)丙基)-4-(8-羟基喹啉-6-基)苯甲酰胺

GSK481

CS-2186

CS-2186

NS 11021

N'-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-N-[4-BROMO-2-(2H-TETRAZOL-5-YL-PHENYL]THIOUREA

N'-[3,5-双(三氟甲基)苯基]-N-[4-溴-2-(2H-四唑-5-基)苯基]-硫脲

MK 571

MK-571钠盐

MK-571钠盐;(E)-3-[[[3-[2-(7-氯-2-喹啉基)乙烯基]苯基][[3-(二甲基氨基)-3-氧代丙基]硫基]甲基]硫基]-丙酸

Pluripotin (SC-1)

PLURIPOTIN

N-[3-[7-[(1,3-二甲基-1H-吡唑-5-基)氨基]-1,4-二氢-1-甲基-2-氧代嘧啶并[4,5-D]嘧啶-3(2H)-基]-4-甲基苯基]-3-(三氟甲基)苯甲酰胺;CS-2337;CS-2160

DMXAA (ASA404)

2,5-己酮可可碱

伐地美生;5,6-二甲基-9-氧-9-氢-氧杂蒽-4-乙酸;CS-1975;5-己酮可可碱;2,5-己酮可可碱VADIMEZAN(DMXAA,ASA-204);2-(5,6-二甲基-9-氧代占吨-4-基)乙酸;5,6-二甲基-9H-氧杂蒽-9-酮-4-乙酸;2,5-己酮可可碱

GNF-7

GNF-7

N-[3-[1,4-二氢-1-甲基-7-[(6-甲基-3-吡啶基)氨基]-2-氧代嘧啶并[4,5-D]嘧啶-3(2H)-基]-4-甲基苯基]-3-(三氟甲基)苯甲酰胺;CS-1945;GNF-7>98%

CX-5461

CX-5461

2-(4-甲基-1H-1,4-二氮杂环庚烷-1-基)-N-[(5-甲基-2-吡嗪基)甲基]-5-氧代-5H-苯并噻唑并[3,2-A][1,8]萘啶-6-甲酰胺;CS-1938;CX-5461;CX 5461;CX5461;CX-5461 500MG

TAK-875

TAK875

CS-1926;(3S)-6-[[2',6'-二甲基-4'-[3-(甲基磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸半水合物

C7280948

C7280948

C 7280948;C-7280948;C7280948>98%;4-氨基-N-(2-苯基乙基)苯磺酰胺

IU1

1-[1-(4-FLUOROPHENYL)-2,5-DIMETHYL-1H-PYRROL-3-YL]-2-(1-PYRROLIDINYL)ETHANONE;IU1

IU1;IU-1;IU 1;1-[1-(4-FLUOROPHENYL)-2,5-DIMETHYL-1H-PYRROL-3-YL]-2-(1-PYRROLIDINYL)ETHANONE;IU1;1-[1-(4-氟苯基)-2,5-二甲基-1H-吡咯-3-基]-2-(1-吡咯烷基)乙酮

HBX 41108

7-氯-9-氧代-9H-茚并[1,2-B]吡嗪-2,3-二甲腈

7-氯-9-氧代-9H-茚并[1,2-B]吡嗪-2,3-二甲腈;CS-1900;HBX 41108;HBX-41108

Tubastatin A Hydrochloride

N-羟基-4-[(1,2,3,4-四氢-2-甲基-5H-吡啶并[4,3-B]吲哚-5-基)甲基]苯甲酰胺盐酸盐

CS-1894;TUBASTATIN A HYDROCHLORIDE;TSA HCL;N-羟基-4-[(1,2,3,4-四氢-2-甲基-5H-吡啶并[4,3-B]吲哚-5-基)甲基]苯甲酰胺盐酸盐;TUBASTATIN A 盐酸盐;1310693-92-5N-羟基-4-[(1,3-B]吲哚-5-基)甲基]苯甲酰胺盐酸盐;新橙皮苷二氢查耳酮,一种有效的选择性HDAC6抑制剂

PD 151746

PD151746

PD 151746,选择性,细胞渗透性的CALPAIN抑制剂;PD-151746;PD 151746;PD151746

GLPG0634

GLPG0634

GLPG0634 N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-cyclopropanecarboxamide;N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-cyclopropanecarboxamide GLPG0634 analogue;GLPG0634 analog, Filgotinib analog;GLPG634 analog;N-(5-(4-((6-cyanopyridin-3-yl)methoxy)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide;N-[5-[4-[(6-Cyano-3-pyridinyl)Methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxaMide (GLPG0634);N-[5-[4-[(6-cyano-3-pyridinyl)Methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-cyclopropanecarboxaMide;GLPG0634 analogue

Dorsomorphin 2Hydrochloride

BML-275

6-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-3-PYRIDIN-4-YLPYRAZOLO[1,5-A]PYRIMIDINE;DIHYDROCHLORIDE;BML-275;COMPOUND C;BML275;BML 275;CS-1883;6-[4-[2-(1-哌啶基)乙氧基]苯基]-3-(4-吡啶基)吡唑并[1,5-A]嘧啶二盐酸盐;BML-275 HCL,物质C盐酸盐;BML-275(2HCL);BML-275;COMPOUND C;BML275;BML 275;BML-275 DIHYDROCHLORIDE;COMPOUND C DIHYDROCHLORIDE;BML275 DIHYDROCHLORIDE;BML 275 DIHYDROCHLORIDE;DORSOMORPHIN (COMPOUND C)2HCL

GSK 2334470

GSK2334470

1S,4R)-3-(6-(3-AMINO-1H-INDAZOL-6-YL)-2-(METHYLAMINO)PYRIMIDIN-4-YL)-N-CYCLOHEXYL-4-METHYLCYCLOHEXAN;CS-1873;GSK2334470;GSK 2334470;GSK-2334470